The Prevalence of Probable Familial Chylomicronemia Syndrome in a Southern California Population
- 1 January 2021
- journal article
- review article
- Published by Elsevier BV in Endocrine Practice
- Vol. 27 (1), 71-76
- https://doi.org/10.4158/ep-2020-0135
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Lipase maturation factor 1: A lipase chaperone involved in lipid metabolismBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2012
- Chylomicronemia mutations yield new insights into interactions between lipoprotein lipase and GPIHBP1Human Molecular Genetics, 2012
- ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)European Heart Journal, 2011
- Two Siblings with Familial Chylomicronemia Syndrome: Disease Course and Effectiveness of Early TreatmentCase Reports in Medicine, 2010
- Chylomicronemia With a Mutant GPIHBP1 (Q115P) That Cannot Bind Lipoprotein LipaseArteriosclerosis, Thrombosis, and Vascular Biology, 2009
- NovelLPLmutations associated with lipoprotein lipase deficiency: two case reports and a literature reviewCanadian Journal of Physiology and Pharmacology, 2009
- Monogenic pediatric dyslipidemias: Classification, genetics and clinical spectrumMolecular Genetics and Metabolism, 2008
- Chylomicronemia and the Chylomicronemia Syndrome: A Practical Approach to ManagementThe American Journal of Medicine, 2008
- APOA5 and triglyceride metabolism, lesson from human APOA5 deficiencyCurrent Opinion in Lipidology, 2006
- Molecular pathobiology of the human lipoprotein lipase genePharmacology & Therapeutics, 1996